Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.23531
Abstract: Morbidity and mortality of immunocompromised patients are increased by primary infection with or reactivation of Epstein-Barr virus (EBV), possibly triggering EBV+ post-transplant lymphoproliferative disease (PTLD). Adoptive transfer of EBV-specific cytotoxic T cells (EBV-CTLs) promises a…
read more here.
Keywords:
ebv;
ebv specific;
immunotherapy;
naturally processed ... See more keywords